Northern Trust Corp Lyell Immunopharma, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,356,077 shares of LYEL stock, worth $827,206. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,356,077

Previous 1,389,041 2.37%

Holding current value

$827,206

Previous $2.01 Million 7.1%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.13 - $1.88 $37,249 - $61,972	-32,964 Reduced 2.37%	1,356,077 $1.87 Million
Q2 2024 Aug 14, 2024	SELL	$1.3 - $3.01 $68,807 - $159,316	-52,929 Reduced 3.67%	1,389,041 $2.01 Million
Q1 2024 May 14, 2024	SELL	$1.71 - $3.07 $57,351 - $102,964	-33,539 Reduced 2.27%	1,441,970 $3.22 Million
Q4 2023 Feb 13, 2024	SELL	$1.39 - $2.35 $10,659 - $18,022	-7,669 Reduced 0.52%	1,475,509 $2.86 Million
Q3 2023 Nov 13, 2023	BUY	$1.45 - $3.35 $70,932 - $163,878	48,919 Added 3.41%	1,483,178 $2.18 Million
Q2 2023 Aug 11, 2023	SELL	$1.89 - $3.86 $560,417 - $1.14 Million	-296,517 Reduced 17.13%	1,434,259 $4.56 Million
Q1 2023 May 15, 2023	SELL	$1.97 - $3.58 $901,793 - $1.64 Million	-457,763 Reduced 20.92%	1,730,776 $4.08 Million
Q4 2022 Feb 13, 2023	BUY	$2.78 - $8.09 $416,505 - $1.21 Million	149,822 Added 7.35%	2,188,539 $7.59 Million
Q3 2022 Nov 14, 2022	BUY	$5.54 - $8.27 $4.62 Million - $6.9 Million	834,445 Added 69.29%	2,038,717 $14.9 Million
Q2 2022 Aug 12, 2022	BUY	$3.68 - $6.8 $558,852 - $1.03 Million	151,862 Added 14.43%	1,204,272 $7.85 Million
Q1 2022 May 13, 2022	BUY	$5.05 - $7.7 $4.25 Million - $6.47 Million	840,833 Added 397.41%	1,052,410 $5.32 Million
Q4 2021 Feb 08, 2022	SELL	$7.13 - $15.19 $16,163 - $34,435	-2,267 Reduced 1.06%	211,577 $1.64 Million
Q3 2021 Nov 15, 2021	BUY	$11.0 - $17.95 $2.35 Million - $3.84 Million	213,844 New	213,844 $3.17 Million

Others Institutions Holding LYEL

# of Institutions

121

Shares Held

142M

Call Options Held

18.1K

Put Options Held

200

View Full List

About Lyell Immunopharma, Inc.

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $151M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

More about LYEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Lyell Immunopharma, Inc. Transaction History